Paychex, Inc. Form 10-Q Summary
Business context and reporting period
Paychex provides payroll, human resource, insurance, retirement, benefits, and related outsourcing solutions primarily to small and medium-sized businesses in the United States, with immaterial operations in Germany. The filing covers the three and nine months ended February 28, 2015, representing fiscal 2015 third-quarter and year-to-date results. The prior comparable periods ended February 28, 2014.
Key financial metrics
| Metric | Three months ended Feb. 28, 2015 | Change | Nine months ended Feb. 28, 2015 | Change |
|---|---|---|---|---|
| Total service revenue | $693.6 million | 8% | $2,016.1 million | 9% |
| Total revenue | $704.3 million | 8% | $2,047.4 million | 9% |
| Operating income | $264.3 million | 5% | $802.0 million | 6% |
| Net income | $169.4 million | 6% | $513.7 million | 7% |
| Diluted EPS | $0.46 | 5% | $1.41 | 8% |
| Operating margin on total revenue | 37.5% | Down from 38.5% | 39.2% | Down from 40.1% |
| Effective tax rate | 36.3% | Down from 36.5% | 36.3% | Down from 36.5% |
Payroll service revenue increased 2% to $423.8 million in the quarter and 4% to $1,247.8 million year to date. Human Resource Services revenue increased 19% to $269.8 million in the quarter and 19% to $768.3 million year to date. Growth reflected client and worksite-employee gains, pricing, product penetration, retirement-services growth, SaaS expansion, and the minimum-premium health insurance offering for PEO clients.
Operating expenses increased 10% in the quarter and 11% year to date. Compensation-related costs rose 9% and 7%, respectively, while other expenses rose 15% and 20%, primarily due to the PEO health insurance offering and investments in product development and supporting technology. Non-GAAP operating income excluding interest on funds held for clients was $253.6 million, or 36.6% of service revenue, versus 37.5% in the prior-year quarter; the year-to-date measure was $770.7 million, or 38.2%, versus 39.1%.
Net cash provided by operating activities was $692.8 million for the nine months, compared with $705.8 million in the prior-year period. Net cash used in investing activities was $1,027.2 million, including $72.0 million of capital expenditures and $27.1 million for business acquisitions. Financing activities provided $447.2 million, including an $891.8 million increase in client fund obligations, offset by $414.4 million of dividends and $70.4 million of share repurchases.
At February 28, 2015, cash and cash equivalents were $265.3 million, corporate investments were $764.1 million, and funds held for clients were $5.1 billion. Total assets were $7.3 billion and stockholders’ equity was $1.9 billion. Paychex reported no debt outstanding. Available borrowing capacity included $900 million under four uncommitted secured lines and a $750 million committed unsecured credit facility, none of which was outstanding at period-end.
Material changes versus the prior comparable period
- HRS revenue growth of 19% materially exceeded payroll revenue growth, partly reflecting the newer PEO minimum-premium health insurance product.
- Revenue growth outpaced operating-income growth, resulting in lower operating margins.
- Net income and diluted EPS increased despite higher operating costs and continued low interest rates.
- Operating cash flow declined by $13.0 million year over year, primarily because of timing-related changes in operating assets and liabilities.
- Share repurchases decreased to $70.4 million from $203.0 million in the prior-year nine-month period. The company repurchased 1.7 million shares year to date under a $350 million authorization expiring May 31, 2017.
- The quarterly dividend increased 9% to $0.38 per share from $0.35.
- Funds held for clients increased to $5.1 billion from $4.2 billion at May 31, 2014, while client fund obligations increased to $5.1 billion from $4.2 billion.
Guidance, outlook, risks, and unusual items
Management said fiscal 2015 guidance was unchanged, assuming current market, economic, and interest-rate conditions continue. Guidance calls for payroll service revenue growth of 3% to 5%, HRS revenue growth of 16% to 19%, total service revenue growth of 8% to 10%, and net income growth of 6% to 8%. Fiscal 2015 capital expenditures are expected to be $110 million to $120 million, depreciation $95 million to $100 million, and intangible amortization slightly below $15 million.
Interest rates remained low, with the combined investment portfolio earning an average rate of 0.9% in the quarter and 1.0% for the nine months. Management expects cash, corporate investments, and operating cash flow to fund operations, capital expenditures, dividends, and repurchases for the foreseeable future. A 25-basis-point change in short-term rates was estimated to affect after-tax earnings by approximately $3.5 million to $4.0 million over the following 12 months. A 25-basis-point increase in longer-term rates could reduce the fair value of available-for-sale securities by approximately $20 million to $25 million, with the effect generally recorded in equity unless impairment occurs.
Key risks include employment and wage trends, interest-rate and investment-credit risk, competition, regulatory changes affecting payroll and employee benefits, health and workers’ compensation claims, technology and cybersecurity failures, dependence on third-party providers, internal-control failures, and legal matters. Workers’ compensation reserves and PEO insurance claims are estimates subject to potentially significant adjustment. Management stated that pending legal matters were not expected to have a material adverse effect, but acknowledged that outcomes remain uncertain.
The company reported no other-than-temporary impairment in its investment portfolio. Available-for-sale securities had $1.2 million of gross unrealized losses and $35.6 million of net unrealized gains at February 28, 2015. Recently issued accounting standards, including revenue recognition guidance, were not expected by management to have a material impact, although the company was evaluating the potential effect of the revenue standard.
Facts investors should verify
- Whether HRS growth remains elevated after the PEO minimum-premium health insurance offering’s initial contribution to results.
- Whether expense growth, particularly compensation, medical, insurance, and technology costs, moderates enough to stabilize operating margins.
- The sensitivity of interest income and investment fair values to changes in short- and long-term interest rates.
- The liquidity and investment risks associated with approximately $5.9 billion of combined client and corporate funds, including municipal bonds and variable-rate demand notes.
- The adequacy of workers’ compensation and health insurance reserves and the potential impact of adverse claims development.
- Future capital allocation among dividends, share repurchases, acquisitions, and product-development investment.
- Progress toward fiscal 2015 guidance and the effect of regulatory, cybersecurity, legal, and third-party service-provider risks.